Retail

Bridal Cosmetics E-Commerce Luxury Office Products Supply Chain Management
News Release Digital Asset Direct

mesoestetic® Selects ToolsGroup AI-Powered Planning To Support Burgeoning Business and Maximize Customer Satisfaction

ToolsGroup

ToolsGroup, a global leader in retail and supply chain planning and optimization software, is proud to announce it has been selected by mesoestetic, a global leader in the medical cosmetics and aesthetic medicine sector, to support the company’s massive business expansion while maintaining a premier customer experience. Founded in Spain in 1985, mesoestetic has grown from a distinguished pharmacy into a world leader in cosmeceutical and nutraceutical products, medical devices, and aesthetic medicine treatments. Its prolific product line – developed in close collaboration with hospitals, universities, and experience specialists – is available in 105 companies. It has a network of 94 official distributors, and 87% of its sales are international. “Thanks to the superior quality of our products, we are experiencing increasing customer demand, propelling us into the international market and spurring tremendous growth,” said Daniel Lancho Navarro, Operations Director at mesoestetic. “We needed a supply chain planning solution with unmatched forecasting to lay the foundation for customer-centric inventory and replenishment planning. Moreover, we built our business on collaborating with the leading minds in our sector. We wanted to carry this same spirit of collaboration and focus on continuous improvement into our supply chain revitalization. With its innovative AI and powerful automated solutions, ToolsGroup was the obvious choice for a supply chain collaborator who could refine our internal processes, support our continued business expansion, and maximize consumer satisfaction worldwide.” Focused on driving business performance and exceeding customer expectations, mesoestetic selected ToolsGroup Service Optimizer 99+ (SO99+), which includes Demand Planning & Forecasting, Inventory Optimization, and Replenishment. Armed with a unique, machine-learning-enhanced forecasting engine, SO99+ predicts and adapts to changes in demand for pinpoint forecast accuracy. It aligns inventory and replenishment plans with operations, improving and accelerating decision making so companies can hit business goals while increasing market share and boosting customer loyalty and satisfaction. “Amid increasing supply chain complexity, organizations are recognizing the tremendous growth potential inherent in the new economic landscape,” remarked ToolsGroup CEO, Inna Kuznetsova. “As AI and automation transition from novel to necessary, we see growth-oriented companies embracing collaborative processes and the latest technological innovations to drive profitable, customer-centric practices. That’s why we’re delighted to partner with mesoestetic on this supply chain transformation journey towards sustained business growth, higher profitability, and continued customer service excellence.” How can ToolsGroup enhance your supply chain management processes? Find out straight from our customers here. About mesoestetic At mesoestetic we are committed to bringing confidence, clarity, and scientific rigor to the world of beauty. From our beginning, 35 years ago, we have been committed to creating products of the highest quality and effectiveness backed by the results of numerous studies. We design home, aesthetic cabin and aesthetic medicine treatments to offer anti-aging, anti-acne, body reshaping, sun protection, and depigmenting solutions, where we are world leaders. We are a pharmaceutical laboratory that we design and produce at our headquarters in Viladecans (Barcelona). This differential factor is essential to guarantee the efficacy, quality and safety of all the treatments we develop, allowing us to control and take care of each step of the value chain. Thanks to all this, doctors, aesthetic professionals, consumers, and skincare experts trust us in more than 90 countries. About ToolsGroup ToolsGroup’s innovative AI-powered solutions enable retailers, distributors, and manufacturers to navigate through supply chain uncertainty. Our retail and supply chain planning suites empower a new level of intelligent decision making and unlock powerful business improvements in forecast accuracy, service levels, and inventory - delighting customers and achieving financial and ESG KPIs. Stay in touch with ToolsGroup on LinkedIn, Twitter, YouTube, or visit www.toolsgroup.com. Contact Details Meir Kahtan +1 917-864-0800 mkahtan@rcn.com Company Website https://www.toolsgroup.com

May 11, 2023 10:30 AM Eastern Daylight Time

Image

Rodedawg Intl. Ind., Inc. (OTC: RWGI) Expands into Healthcare with Acquisition of Elixicure™ Pain Relief

Rodedawg International Industries, Inc.

Rodedawg International Industries, Inc. (OTC: RWGI) Inc. proudly announces its expansion into the healthcare industry with the purchase of Elixicure™ Pain Relief. Chris Swartz, CEO of Rodedawg states, “We are very proud to announce to our shareholders that Rodedawg has acquired Elixicure™ and all its assets. Our shareholders are benefitting from the roadmap of 6 years of healthcare marketing experience and the evolution of the Elixicure™ brand. The Elixicure™ team raised over 3 and ½ million dollars and we are acquiring not only physical production equipment but we are gaining years of research, finalized formulas, packaging, branding, brand awareness and established revenue producing sales channels. The acquisition includes manufacturing equipment, transportation and warehouse equipment, sales personnel and sales channels with growing revenue streams. In its first few years of operation the company expanded exponentially and generated close to 1 million in revenues within 3 years of its start. The product set is already embedded in regional sports culture and has been a great success in chiropractic and healthcare centers. Rodedawg personnel will be adding to the management team and we fully expect to see Elixicure™ generate over 3 million in its first year as a Rodedawg company. This acquisition gives Rodedawg an the entrance into the multi-billion dollar pain relief market.” Chris Swartz, CEO, adds, “According to Allied Market Research, the global topical pain relief market size was valued at $8.8 billion in 2019, and is projected to reach $12.2 billion by 2027 at a CAGR of 5.2% from 2020 to 2027. This is a massive market and this acquisition positions the company to expand into products and services generating revenue streams back to the Rodedawg enterprise. Until the SAFE Banking ACT and national legalization of cannabis, this acquisition allows Rodedawg to develop channels of distributions with marketing and sales of products in mainstream national markets. Additionally, we will also be informing our shareholders of our expanded sales and marketing plan for Elixicure™ and a wide range of health care products with multi-faceted distribution sales channels.” Mr. Swartz concludes, “In the next few weeks, management will further inform shareholders on the timeframe and progress of accomplishing success milestones to further expand shareholder value. Behind the scenes, we are lining up additional acquisitions, cancellation of shares, and completion of our audit, as our plan from the beginning has been positioning the Company for significant growth leading to uplisting.” About Rodedawg International Industries, Inc. Rodedawg International Industries, Inc. (OTC: RWGI) is focused on providing management services, acquisitions, and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries Please note, the company's Twitter address is https://twitter.com/RWGImerger for regular updates. About Elixicure™ Elixicure™ Pain Relief creates, manufacturers and distributes high quality, organic pain relief without chemical additives. Founded in 2017 by two brothers who made it their mission to help their mother and the world by creating the best natural pain relief. The company website is https://elixicure.com/ Social Channels include: Facebook: https://www.facebook.com/Elixicure/ Instagram: https://www.instagram.com/elixicure/?hl=en https://www.youtube.com/channel/UC0FbyKmTYOxs6UTU_04F-mQ Purchase Online with Walmart at https://www.walmart.com/ip/Elixicure-All-Natural-Pain-Relief-Cream-Roll-on-Lavender-Scent Purchase Online with Amazon at https://www.amazon.com/Elixicure-Pain-Relief About Budding Horizon, LLC Budding Horizon, LLC is a California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis portfolio of assets. The company website is https://buddinghorizon.com/ Contact Information: Rodedawg International Industries, Inc. 1-800-793-0355 ir@buddinghorizon.com Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements. SOURCE: Rodedawg International Industries, Inc. Contact Details Rodedawg International Industries, Inc ir@buddinghorizon.com

May 11, 2023 09:30 AM Eastern Daylight Time

Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that its subsidiary Evolutionary Biologics, Inc. (“EvoBio”), a developer, manufacturer and distributor of private label regenerative medicine products and branded state-of-the-art biologic products, created in a pharmaceutical grade laboratory and manufacturing facility has executed a Product Manufacturing Agreement with a distributor of medical devices that desires to market a MSC Exosome product from EvoBio as a private label on an exclusive basis. The Company believes the new relationship will generate at least $2 million in new revenue. Jim Morrison, former L'Oréal President and Emergent’s full time CEO stated, “Our expansion of Evolutionary Biologics has continued beyond our original strategy. As I mentioned earlier this year, we have created a relationship with a state-of-the-art laboratory which has enabled us to not only manufacture the highest quality products for ourselves, but to manufacture world class products for strategic partners that can be marketed as “private label.” This new initiative comes as we continue to prepare the company for major growth and expansion.” On Tuesday of this week, Emergent announced the engagement of BF Borgers CPA PC, a full-service audit, tax, accounting, and advisory firm, as its Public Company Accounting Oversight Board (“PCAOB”) qualified auditor to audit the Company’s PharmaZu subsidiary’s financial statement for the two-year period ending December 31, 2022 according to Generally Accepted Accounting Principles (“GAAP”). GAAP is the accounting standard adopted by the Securities and Exchange Commission (“SEC”) and is the default accounting standard used by companies based in the United States. For further information, please see Press Release dated May 9 th, 2023. On Thursday of last week, Emergent announced the engagement of Boustead Securities LLC. to act as exclusive financial advisor with respect to a planned corporate financing transaction including the private placement of securities (“pre-IPO Financing”) and a planned $10 million initial public offering of Emergent;s subsidiary, PharmaZu and its common stock (“IPO”) that will apply for listing on NASDAQ with NO DILUTION to the Emergent Shareholders. PharmaZu is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness, using Influencers and their content, including pet pharmacy, vet telehealth and pet wellness businesses. Upon the effectiveness of the IPO and listing on NASDAQ, PharmaZu plans to acquire a 48-state authorized compounding pharmacy located in West Palm Beach, FL, doing approximately $10M a year in revenue, which will serve as the backbone and fulfilment center for PharmaZu, creating a national platform throughout the United States. The raise of capital will be used for expanding PharmaZu’s business, product offerings, as well as for acquisitions. Subsequently, Emergent plans to distribute the shares of PharmaZu as a dividend to its shareholders, pro rata at NO COST to the Emergent Shareholders. For further information, please see Press Release dated May 4 th, 2023. ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website info@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 11, 2023 09:00 AM Eastern Daylight Time

Image

Floe Oral Care receive £419k of grant funding from Innovate UK to combine artificial intelligence and salivary diagnostics

Floe

Floe Oral Care, a London-based healthtech startup, has won a grant for the development of its oral health test to monitor oral and systemic health through the power of saliva.The funding will enable the team to develop a machine learning algorithm that will search for patterns in order to uncover new insights and make predictions about the development of oral disease and its impact on the rest of the body. These insights will subsequently drive behaviour changes, both in terms of product and lifestyle recommendations, and the need for professional dental care. Our mouth is the primary gateway to our body, serving as the first line of defense against pathogens or, in cases of poor oral health, opening the floodgates to infection and inflammation throughout the body. A growing body of scientific literature shows how chronic inflammation of the mouth increases the risk of cardiovascular disease, diabetes and even Alzheimers, and yet we continue to treat our oral health as an afterthought. Floe wants to change that by giving oral health its rightful place as a fundamental pillar of overall health and wellbeing. “Everyone knows prevention is better than cure. In reality though, getting access to some of the most impactful and motivating information there is — data about how you’re really doing on the inside —is extremely difficult and costly” Floe co-founder and CEO William Welton says. The NHS is an incredible institution and is mostly ‘free’ but because it’s so challenging to access, people have to wait until they’re sick before lifting the lid on their bodies. The consequence? We’re locked in a reactive health paradigm. Until now, people haven’t been able to access the tools that enable them to take control; to own and to make better decisions about their health. By providing them with key insights, Floe’s aim is not only to empower and motivate the user but also to help the NHS direct resources to where they are most needed. Floe’s current investors include Holland & Barrett and various high-profile angels in the healthcare and commercial sectors. Recent Floe investor Avi Lasarow, who founded DNAfitand took Prenetics public on Nasdaq as CEO commented: “ Withover 20 years experience building innovative health businesses, I know you need the perfect combination of team and tech, and the guys at Floe have both in abundance. I look forward to supporting the business as they grow and seeing Floe change the way we approach oral care for years to come.” Join the waiting list for Floe’s oral health test here. Contact Details Floe Oral Care Will Welton will@getfloe.com Company Website https://getfloe.com/

May 11, 2023 07:00 AM Eastern Daylight Time

Transforming Plastic Waste Management: The Impact of SMX’s Track and Trace System

Security Matters PLC

Plastic waste has emerged as one of the most pressing environmental issues of the 21st century, posing significant threats to ecosystems and life on Earth. Each year, millions of tons of plastic waste end up in our oceans, landfills, and even in remote parts of the world, causing devastating impacts on wildlife, marine life, and the overall health of our planet. These synthetic materials, designed for durability and longevity, can take hundreds of years to decompose, thereby persisting in the environment for extended periods. Microplastics, tiny fragments resulting from the breakdown of larger plastic items, have infiltrated even the most remote corners of the globe and are increasingly found in the food chain. Moreover, the production and disposal of plastics contribute significantly to greenhouse gas emissions, further exacerbating climate change. Addressing the plastic waste crisis requires innovative solutions that not only enhance recycling efficiency but also promote a circular and sustainable economy. SMX’s Innovative Technologies Stands Ready To Help Improve The Pressing Plastic Waste Issue SMX (NASDAQ: SMX), is an innovative circular economy company, set to revolutionize the plastics industry with its cutting-edge track and trace technology. This organization is dedicated to digitizing physical objects on the blockchain, a strategy aimed at promoting a circular and closed-loop economy. Their patented technology utilizes an indelible chemical-based biomarker to "mark" any object—solid, liquid, or gas. This unique barcode can be deciphered using the company's proprietary 'reader,' which pulls up the corresponding stored data, safeguarded by the immutable nature of blockchain technology. In April 2022, the company made headlines in the recycling world after successfully concluding commercial readiness trials for their pioneering plastic tracking system. At the heart of this innovation is an industrial-grade identification, authentication, and sorting conveyor belt designed specifically for the plastics sector. As they anticipate the commercial deployment of this revolutionary technology, SMX is actively engaged in promising discussions with various strategic partners, promising a new era for plastic recycling. SMX Technology Can Track and Trace Plastic Throughout Its Lifecycle, Helping the Environment & The Plastics Industry SMX’s innovative technology stands to greatly benefit the plastics industry by reducing waste and increasing recycling, ultimately bolstering environmental sustainability while also enhancing the industry's efficiency. Their patented marking technology, which assigns a unique chemical-based biomarker to objects, enables an unprecedented level of tracking and tracing throughout the lifecycle of plastic products. This paves the way for more effective sorting and recycling, since stakeholders can now precisely identify the type of plastic, the manufacturer, the percentage of recycled content, and even the number of times it has been recycled. The revolutionary conveyor belt detector, an integral component of their comprehensive solution, provides reliable data readings at every stage of the supply chain. This allows stakeholders to seamlessly transfer ownership of materials and products, record essential data, and attach critical documents via the intuitive interface. This game-changing innovation provides unparalleled transparency, enabling users to effortlessly track and trace plastic packaging throughout every stage of the value chain, from sorting to mechanical recycling. Such heightened transparency and traceability facilitates the creation of a digital twin of the product, thus illuminating every stage of its value chain. This can drastically improve the sorting capabilities of recycling and waste management facilities, and subsequently increase the percentage of plastic that is effectively recycled. By doing so, SMX’s technology aids in driving a more sustainable future for plastics, promoting a circular and closed-loop economy that mitigates plastic waste and its associated environmental impact. Moreover, this cutting-edge system has the potential to unlock the ability to reclaim and reuse all types of plastic content, bridging the gap for plastic circularity. By offering a solution that can be customized to individual requirements, such as detecting specific "marked" polymers among other waste, SMX is well-positioned to revolutionize plastic waste management and recycling. The versatility of SMX’s technology extends its applications across a broad range of industries from automotive to electronics, fashion and food. The chemical-based marker is applicable to solids, liquids, and gases, while the conveyor belt system can be tailored to specific needs, such as reading various types of packaging, detecting marked polymers among other waste, and modifying the dimensions and speed of the conveyor belt. As global concerns about plastic waste and sustainability persist, SMX’s innovative track and trace technology offers a promising solution to increase recycling efficiency and foster a circular and closed-loop economy in the plastics industry. Disclaimer: Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement. All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated seven hundred and fifty dollars cash by a third party, Vince Caruso and FMW Media Works Corp. for the creation and dissemination of this content. This material does not represent a solicitation to buy or sell any securities. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management. The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions. Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/ The Post " Transforming Plastic Waste Management: The Impact of SMX’s Track and Trace System " First Appeared On Spotlight Growth. Contact Details SMX Spotlight Growth info@spotlightgrowth.com

May 10, 2023 01:20 PM Eastern Daylight Time

News Release

Givex starts 2023 on a strong footing with positive first-quarter organic and acquisitive growth

Givex Corp

Givex Corp CEO Don Gray joined Proactive's Stephen Gunnion with details of the company's first-quarter results, which reveal a 17% rise in revenue to $19.2 million for the three months to March 31, 2023, as it grew customer locations and gross transactional value. As well as organic growth, Gray said the 1Q performance was boosted by last year's acquisitions. The company expects growth to continue throughout the year and is looking to make more acquisitions in the third or fourth quarter, he added. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

May 10, 2023 11:34 AM Eastern Daylight Time

Video

What indie beauty brand do Sharon Stone, Katie Couric, Naomi Watts and Gwyneth Paltrow all love?

Biography

Sharon Stone says it’s like “caviar for the skin.” Naomi Watts posted an Instagram “shelfie” featuring her favorite, Gwyneth Paltrow chose it for her Goop gift guide and Katie Couric continues to rave about it on her social media. So, what’s the buzz all about? Linda Thompson founded her beauty brand, Biography in 2020. The line is made up of high-quality, carefully blended “active” oils for face; and now NEW oil-infused formulas for the body, all designed to protect the skin and leave it clarified, rejuvenated, hydrated and renewed. Thanks to celebrity makeup artists who constantly request Biography for their clients, in just two short years, the brand has developed a cult-like following, and has been picked up by top retailers including Bergdorf Goodman and Neiman Marcus. Here’s why. Actives are ingredients that actively work toward an intended purpose or specific skincare concern. These ingredients have been proven scientifically to change the structure of the skin at a cellular level. They work to repair, rejuvenate, hydrate, protect and nourish cells. Biography uses these potent “active” ingredients at carefully blended concentrations to address specific concerns. “For people with sensitive, oily, or acne-prone skin, we recommend Long June calm face oil. It contains lightweight, soothing chamomile and apricot seed oil, so it absorbs quickly and leaves the skin feeling moisturized and soothed,” explains Thompson. One of the star ingredients in Biography’s Petty Grudges repair blend is rosehip seed oil, vitamin C phenols, and trans-retinoic acid that help repair UV damage, lighten dark spots, and soften fine lines. Biography’s Golden Ray glow face oil contains a few different actives, one of which is French marine algae. “At the concentration in Golden Ray, that algae is clinically proven to stimulate collagen production, which improves elasticity and softens wrinkles,” Thompson says. “Carrot seed oil — another active that’s packed with vitamins A, C, and E — works in tandem to help repair sun damage and scars, boost collagen, and moisturize your skin. It’s a really powerful, but gentle, product great for people with aging or damaged skin,” Thompson says. Thompson recommends applying face oil on damp skin so it locks in hydration for a longer-lasting, dewy look. Regardless of post-cleansing products, face oils should be the final step in a skincare routine. This is because oils create an occlusive layer on the skin, which not only seals in moisture but creates a smooth canvas under sunscreen and makeup. In addition to the newness of the mini size oils, created due to popular demand, the brand has just launched an oil-infused Hand and Body Wash and a Hand and Body Cream. The wash is a gel-like cleanser that gently purifies skin, while finely-ground Quartz and Pumice work to exfoliate leaving skin softened and buffed. Other actives include Butterfly Bush and White Peony. The Hand and Body Cream is instantly absorbed and offers up to 12 hours of hydration with skin-softening effects thanks to ingredients like Babassu seed oil, Butterfly Bush, Camellia seed oil, and a Watermelon/Quinoa blend. Both the Wash and Cream are available in two unique scents. First Edition is reminiscent of a private library in an old-world cathedral, with scents of leather-bound folios, pencil shavings, musty floorboards with a whiff of freshly picked early blooms. O pen Garden suggests a bursting, humid greenhouse with fresh, yet tender blossoms. Think if Monet’s ‘Water Lilies’ were a clean fragrance. The full Biography line is now available at www.biographynyc.com Contact Details Biography Dianne Vavra - Spotlight Beauty PR +1 917-331-4869 Company Website https://biographynyc.com/

May 10, 2023 09:07 AM Eastern Daylight Time

Image

Nextech3D.AI secures contract renewal and expansion contract for 3,000 3D models

Nextech3D.AI

Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to share news that a major eCommerce brand has agreed to a renewal and expansion 3D modeling deal that will see the company produce another 3,000 models. Gappelberg telling Proactive the client operates in various industries such as retail, shopping malls, entertainment, and real estate and is considered a major player in the Middle East, North Africa, and Central Asia regions. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

May 10, 2023 08:26 AM Eastern Daylight Time

Video

Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that it has engaged BF Borgers CPA PC, a full-service audit, tax, accounting, and advisory firm, as its Public Company Accounting Oversight Board (“PCAOB”) qualified auditor to audit the Company’s financial statement for the two-year period ending December 31 st, 2022 according to Generally Accepted Accounting Principles (“GAAP”). GAAP is the accounting standard adopted by the Securities and Exchange Commission (“SEC”) and is the default accounting standard used by companies based in the United States. Just last week on Thursday May 4 th, 2023, Emergent executed an Engagement Letter with Boustead Securities LLC. to act as exclusive financial advisor with respect to a planned corporate financing transaction including the private placement of securities (“pre-IPO Financing”) and a planned $10 million initial public offering of Emergent subsidiary PharmaZu common stock (“IPO”) that will apply for listing on NASDAQ with NO DILUTION to the Emergent Shareholders. PharmaZu is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including pet pharmacy, vet telehealth and pet wellness businesses. Upon the effectiveness of the IPO and listing on NASDAQ, PharmaZu plans to acquire a 48-state authorized compounding pharmacy located in West Palm Beach, FL, doing approximately $10M a year in revenue, which will serve as the backbone and fulfilment center for PharmaZu, creating a national platform throughout the United States. The raise of capital will be used for expanding PharmaZu’s business, product offerings, as well as for acquisitions. Subsequently, Emergent plans to distribute the shares of PharmaZu as a dividend to its shareholders, pro rata at NO COST to the Emergent Shareholders. Jim Morrison, former L'Oréal President and Emergents full time CEO stated, “As we first announced last week, the PharmaZu IPO is not only an enormous opportunity for the founders and leadership of PharmaZu, it is also a seminal event for the shareholders of Emergent Health. We are very serious about the PharmaZu IPO and have selected a "best-in-class" audit firm in B F Borgers as our 'PCAOB' audit firm. They are consummate professionals, and we are looking forward to working with the firm.” The execution of the Engagement Letter does not constitute a commitment by Boustead or the Company to consummate any transaction contemplated hereunder and does not ensure the successful placement of securities of any investment vehicle or the success of Boustead with respect to finding any investors or the success with respect to any transaction. No promises, representations or guarantees have been made. ABOUT BOUSTEAD SECURITIES, LLC Boustead Securities, LLC is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority-owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information visit please visit: www.boustead1828.com ABOUT BF BORGERS CPA PC BF Borgers CPA PC is based in Lakewood, Colorado and is registered as a Public Company Accounting Oversight Board (PCAOB) listed firm. At BF Borgers CPA PC we have built our practice by providing exceptional service to our clients through our commitment to our firm’s culture and values based on the three underlying principals Professionalism, Responsiveness and Quality. For More information, please visit BF Borgers CPA PC. ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website i nfo@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 09, 2023 09:15 AM Eastern Daylight Time

1 ... 130 131 132 133 134 ... 251